Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2531795019 | Alpha 4 integrin antagonist (substance) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2535351019 | Alpha 4 integrin antagonist | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2538011013 | A4 integrin antagonist | en | Synonym | Inactive | Case sensitive | SNOMED CT core |
| 3520613019 | Alpha-4 integrin receptor antagonist | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3636173010 | Substance with alpha-4 integrin receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3636174016 | Substance with alpha-4 integrin receptor antagonist mechanism of action | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Alpha-4 integrin receptor antagonist | Is a | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
| Alpha-4 integrin receptor antagonist | Has disposition | Alpha-4 integrin receptor antagonist | true | Inferred relationship | Some | ||
| Alpha-4 integrin receptor antagonist | Has disposition | Immunomodulator | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Natalizumab | Is a | True | Alpha-4 integrin receptor antagonist | Inferred relationship | Some | |
| Alpha-4 integrin receptor antagonist-containing product | Has active ingredient | True | Alpha-4 integrin receptor antagonist | Inferred relationship | Some | 1 |
| Vedolizumab | Is a | True | Alpha-4 integrin receptor antagonist | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR